Low Concentration of Quercetin Antagonizes the Invasion and Angiogenesis of Human Glioblastoma U251 Cells

Overview

Journal Onco Targets Ther

Publisher Dove Medical Press

Specialty Oncology

Date 2017 Sep 2

PMID 28860810

Citations 23

Authors

Yue Liu

Zhen-Gang Tang

Jian-Quan Yang

Yi Zhou

Ling-Hu Meng

Heng Wang

Cai-Li Li

Affiliations

Soon will be listed here.

Abstract

Glioblastoma is the most aggressive type of brain tumor with a very poor prognosis. Therefore, it is always of great importance to explore and develop new potential treatment for glioblastoma. Quercetin, a flavonoid present in a variety of human foods, has been shown to inhibit various tumor cell proliferation. In this study, we found that treating human glioblastoma U251 cells with 10 μg/mL quercetin for 24 hours, a concentration that was far below the IC (113.65 μg/mL) and at which quercetin failed to inhibit cell proliferation, inhibited cell migration (30%) and cell invasion as examined by wound scratch assay and transwell assay, respectively. We further showed that 10 μg/mL quercetin inhibited cell migration and tube formation of human umbilical vein endothelial cells induced by the conditioned medium derived from U251 cell culture. The inhibitory effect of quercetin on migration and angiogenesis is possibly mediated through the downregulation of protein levels of VEGFA, MMP9, and MMP2 as detected by Western blot. Our findings demonstrated that low concentration of quercetin antagonized glioblastoma cell invasion and angiogenesis in vitro.

Citing Articles

Advances in nano-delivery of phytochemicals for glioblastoma treatment.

Ambele M, Maebele L, Mulaudzi T, Kungoane T, Damane B Discov Nano. 2024; 19(1):216.

PMID: 39718730 PMC: 11668727. DOI: 10.1186/s11671-024-04172-9.

Cancer Prevention and Treatment with Polyphenols: Type IV Collagenase-Mediated Mechanisms.

Pawlowski W, Caban M, Lewandowska U Cancers (Basel). 2024; 16(18).

PMID: 39335164 PMC: 11430265. DOI: 10.3390/cancers16183193.

Temozolomide and flavonoids against glioma: from absorption and metabolism to exosomal delivery.

Verma P, Joshi H, Singh T, Sharma B, Sharma U, Ramniwas S Naunyn Schmiedebergs Arch Pharmacol. 2023; 397(1):41-57.

PMID: 37566307 DOI: 10.1007/s00210-023-02660-w.

Amyloids and brain cancer: molecular linkages and crossovers.

Singh S, Joshi V, Upadhyay A Biosci Rep. 2023; 43(10).

PMID: 37335084 PMC: 10548166. DOI: 10.1042/BSR20230489.

Neurotherapeutic Effects of Quercetin and Its Metabolite Compounds on Cognitive Impairment and Parkinson's Disease: An In Silico Study.

Nguyen H Eur J Drug Metab Pharmacokinet. 2023; 48(2):151-169.

PMID: 36848007 DOI: 10.1007/s13318-023-00816-w.

References

Stupp R, Hegi M, Mason W, van den Bent M, Taphoorn M, Janzer R . Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009; 10(5):459-66. DOI: 10.1016/S1470-2045(09)70025-7. View

Kiekow C, Figueiro F, Dietrich F, Vechia L, Pires E, Jandrey E . Quercetin derivative induces cell death in glioma cells by modulating NF-κB nuclear translocation and caspase-3 activation. Eur J Pharm Sci. 2016; 84:116-22. DOI: 10.1016/j.ejps.2016.01.019. View

Fadul C, Wen P, Kim L, Olson J . Cytotoxic chemotherapeutic management of newly diagnosed glioblastoma multiforme. J Neurooncol. 2008; 89(3):339-57. DOI: 10.1007/s11060-008-9615-4. View

Pratheeshkumar P, Budhraja A, Son Y, Wang X, Zhang Z, Ding S . Quercetin inhibits angiogenesis mediated human prostate tumor growth by targeting VEGFR- 2 regulated AKT/mTOR/P70S6K signaling pathways. PLoS One. 2012; 7(10):e47516. PMC: 3475699. DOI: 10.1371/journal.pone.0047516. View

Bischoff S . Quercetin: potentials in the prevention and therapy of disease. Curr Opin Clin Nutr Metab Care. 2008; 11(6):733-40. DOI: 10.1097/MCO.0b013e32831394b8. View

Lai W, Hsu S, Chueh F, Chen Y, Yang J, Lin J . Quercetin inhibits migration and invasion of SAS human oral cancer cells through inhibition of NF-κB and matrix metalloproteinase-2/-9 signaling pathways. Anticancer Res. 2013; 33(5):1941-50. View

Kuo P, Liu H, Chao J . Survivin and p53 modulate quercetin-induced cell growth inhibition and apoptosis in human lung carcinoma cells. J Biol Chem. 2004; 279(53):55875-85. DOI: 10.1074/jbc.M407985200. View

Roy R, Yang J, Moses M . Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer. J Clin Oncol. 2009; 27(31):5287-97. PMC: 2773480. DOI: 10.1200/JCO.2009.23.5556. View

Rousseau A, Mokhtari K, Duyckaerts C . The 2007 WHO classification of tumors of the central nervous system - what has changed?. Curr Opin Neurol. 2008; 21(6):720-7. DOI: 10.1097/WCO.0b013e328312c3a7. View

10.

Galluzzo P, Martini C, Bulzomi P, Leone S, Bolli A, Pallottini V . Quercetin-induced apoptotic cascade in cancer cells: antioxidant versus estrogen receptor alpha-dependent mechanisms. Mol Nutr Food Res. 2009; 53(6):699-708. DOI: 10.1002/mnfr.200800239. View

11.

Gryglewski R, Korbut R, Robak J, Swies J . On the mechanism of antithrombotic action of flavonoids. Biochem Pharmacol. 1987; 36(3):317-22. DOI: 10.1016/0006-2952(87)90288-7. View

12.

Simons M, Gordon E, Claesson-Welsh L . Mechanisms and regulation of endothelial VEGF receptor signalling. Nat Rev Mol Cell Biol. 2016; 17(10):611-25. DOI: 10.1038/nrm.2016.87. View

13.

Boots A, Haenen G, Bast A . Health effects of quercetin: from antioxidant to nutraceutical. Eur J Pharmacol. 2008; 585(2-3):325-37. DOI: 10.1016/j.ejphar.2008.03.008. View

14.

Lee T, Kim O, Kim Y, Lim J, Kim S, Park J . Quercetin arrests G2/M phase and induces caspase-dependent cell death in U937 cells. Cancer Lett. 2005; 240(2):234-42. DOI: 10.1016/j.canlet.2005.09.013. View

15.

Hollman P, Katan M . Absorption, metabolism and health effects of dietary flavonoids in man. Biomed Pharmacother. 1997; 51(8):305-10. DOI: 10.1016/s0753-3322(97)88045-6. View

16.

Kumazawa Y, Kawaguchi K, Takimoto H . Immunomodulating effects of flavonoids on acute and chronic inflammatory responses caused by tumor necrosis factor alpha. Curr Pharm Des. 2006; 12(32):4271-9. DOI: 10.2174/138161206778743565. View

17.

Friedl P, Wolf K . Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer. 2003; 3(5):362-74. DOI: 10.1038/nrc1075. View

18.

Sakanashi Y, Oyama K, Matsui H, Oyama T, Oyama T, Nishimura Y . Possible use of quercetin, an antioxidant, for protection of cells suffering from overload of intracellular Ca2+: a model experiment. Life Sci. 2008; 83(5-6):164-9. DOI: 10.1016/j.lfs.2008.05.009. View

19.

Ono K, Nakane H, Fukushima M, Chermann J, Barre-Sinoussi F . Differential inhibitory effects of various flavonoids on the activities of reverse transcriptase and cellular DNA and RNA polymerases. Eur J Biochem. 1990; 190(3):469-76. DOI: 10.1111/j.1432-1033.1990.tb15597.x. View

20.

Kim J, Kim E, Park S, Lim J, Kwon T, Choi K . Quercetin sensitizes human hepatoma cells to TRAIL-induced apoptosis via Sp1-mediated DR5 up-regulation and proteasome-mediated c-FLIPS down-regulation. J Cell Biochem. 2008; 105(6):1386-98. DOI: 10.1002/jcb.21958. View